Cancer Epidemiology, Population & Global Health
About our research programme
Our work covers diverse areas such as cancer epidemiology, health services research, health policy and global health.
Our research into the control of risk-factors and the prevention of cancer, the early diagnosis and detection of cancer and pre-cancer, patients’ experiences of treatment and care and inequalities in their prognosis, treatment and survival both nationally and internationally all contribute to the development of cancer policies and the organisation of cancer services.
Our programme comprises four research groups working collaboratively on seven research themes:
- Cancer Prevention
- Cancer Screening
- Cancer Epidemiology and Cancer Services Research
- Translational Oncology and Urology Research (TOUR)
- Cancer Policy and Global Health
- Clinical Trials
- Cancer Behavioural Science
Members of the programme
- Elizabeth Davies, Programme co-ordinator and Clinical Reader in Cancer and Public Health
- Ajay Aggarwall, Consultant in Clinical Oncology
- Mark Ashworth, Reader in Primary Care
- Kerri Beckmann, Research Associate
- Robert Carr, Consultant Haematologist
- Danielle Crawley, Clinical Lecturer in Cancer Epidemiology
- Margreet Lüchtenborg, Lecturer in Cancer Epidemiology
- Laura Marlow, Senior Research Fellow
- Henrik Møller, Professor of Cancer Epidemiology
- Arnie Purushotham, Co-Director of King's Health Partners Comprehensive Cancer Centre and Professor of Breast Cancer
- Thomas Round, GP and NIHR Doctoral Research Fellow
- Aida Santa Olalla, Senior Data Scientist and Senior Research Fellow
- Peter Sasieni, Professor of Cancer Prevention and Academic Director, King's Clinical Trials Unit
- Richard Sullivan, Professor of Cancer Policy and Global Health
- Mieke Van Hemelrijck, Head of TOUR and Reader in Cancer Epidemiology
- Jo Waller, Reader in Cancer Behavioural Science
Associated academics and researchers
- Cecilia Bosco, Visiting Research Associate
- Carlo Caduff, Senior Lecturer, Anthropology of Cancer, Global Health & Social Medicine
- Lindsay Forbes, Visiting Senior Lecturer in Cancer and Public Health
- Hans Garmo, Visiting Senior Statistician
- Christel Häggström, Visiting Research Associate
- Richard Harding, Herbert Dunhill Professor of Palliative Care, Cicely Saunders Institute of Palliative Care, Policy & Rehabilitation
- Netty Kinsella, Visiting Research Associate
- Grant Lewison, Senior Bibliometrician and Policy Analyst
- Paula Lorgelly, Visiting Professor of Health Economics
The Cancer Research UK & King’s College London Cancer Prevention Trials Unit is a core-funded trials unit bringing a unique capability to the CRUK CTU network with its focus on the design and management of cancer prevention trials. We aim to advance cancer prevention, early diagnosis and screening through clinical trials and other well-designed clinical studies by supporting investigators at King’s and throughout the UK.
The Cancer Screening team is largely funded through a programme grant from Cancer Research UK. We evaluate existing screening programmes and study new technologies and innovations that might lead to new or improved screening programmes. The focus of existing programmes is how to optimise the efficacy and cost-effectiveness and minimise the harms of screening. We are particularly interested in stratified screening and the interface between population screening and targeted early diagnosis.
The work of the Cancer Behavioural Science Group focuses on cervical cancer prevention and aims to better understand non-participation in cervical screening and HPV vaccination. We also assess the psychological impact of screening participation and public attitudes to new developments including risk stratification. We have expertise in both qualitative and quantitative methodological approaches and also carry out online experimental studies.
Cancer Epidemiology and Cancer Services Research covers the study of national and international variation in cancer occurrence, care and outcomes which contributes policy-relevant information to inform the political economy of cancer. Our research covers surveillance, statistics, social medicine and public health. We have a particular focus on studying potential inequalities that may occur in the early detection, diagnosis, experiences of care and cancer outcomes for people diagnosed with cancer both in England and internationally.
The Translational Oncology and Urology Research (TOUR) team aims to turn science into better healthcare by translating uro-oncology research into medical practice. TOUR brings together a team of researchers, clinicians, research nurses, trial co-ordinators, database managers and students who are active across the field of translational research. The translational research work of the group encompasses a heterogeneous set of activities in the area of prostate, bladder, renal and testicular cancer, covering both bedside and bench, specifically focusing on clinical and molecular immunology, bioinformatics, immunology, clinical trials and patient care and experience through the linkage with various biobanks and real world evidence datasets.
Our research into Cancer Policy and Global Health is concerned with the study of global systems of cancer care, research and education to understand how these operate as complex adaptive systems and the development of complex, multi-disciplinary interventions for healthcare systems, models and pathways of care, particularly for vulnerable populations in low resource, conflict impacted populations. We also explore how society, technology and political systems can deliver better patient outcomes with higher value for countries and regions within the context of equality and affordability in collaboration with colleagues at King’s in Global Health and Social Medicine, the Cicely Saunders Institute for Palliative Care and the School of Security Studies. Policy of cancer awareness, screening and early diagnosis is conducted within the NIHR Policy Research Unit on Cancer Awareness, Screening and Early Diagnosis.
To find out more about the Programme please contact Elizabeth Davies.
We work with King's Health Partners (KHP) Comprehensive Cancer Centre to develop local cancer prevention and health promotion strategies and we collaborate with colleagues in general practice in London and Sweden to explore cancer diagnostics and early diagnosis in primary care. The TOUR team initiated and co-ordinates the KHP Uro-Oncology Programme, a multi-disciplinary group of clinicians and scientists with expertise across the fields of epidemiology, bioinformatics and statistics, clinical medicine, cell and molecular biology and immunology, working together to make life-altering discoveries for men affected by urological cancers.
We collaborate closely with colleagues working in the Public Health England National Cancer Registration and Analysis Service (NCRAS) within Public Health England (PHE) on studies of patient experience and outcomes for breast, lung, prostate, colorectal, pancreatic and brain cancer. We have NIHR funding for the first study of cancer in the English prison population in collaboration with the University of Surrey, University College London, University College London Hospitals, Revolving Doors Agency and the Mental Health Foundation.
We are partners in the MRC and CRUK funded Re-IMAGINE Consortium to help define a signature for low-risk prostate cancer as well as the IMI funded PIONEER Consortium – a big data collaborative for prostate cancer led by the European Association of Urology.
We work with many international agencies and governments to assist in their national cancer control planning and with a variety of global and national research and capacity networks, for example, the International Association of Research on Cancer (IARC), the National Cancer Grid of India, the National Cancer Forum of Chile, Union for International Cancer Control, NCI Centre for Global Health, the International Atomic Energy Agencies Program Against Cancer (PACT) and as advisors to the NCD program of the World Health Organisation. We also study and develop cancer control solutions for vulnerable populations for example cancer care in conflict R4HC-MENA program (r4hc-mena.org).